Latest Breaking News On - Neuren pharmaceuticals - Page 1 : comparemela.com

This ASX 200 healthcare stock is up 48% in a year, but one director is still buying!

One of the directors of this ASX 200 healthcare stock has just invested almost $100,000 of his own money and lifted his stake by 50%.

Why Cettire, Neuren, Peter Warren, and Qantas shares are falling today

Cettire Ltd (ASX: CTT) and Qantas Airways Limited (ASX: QAN) are two of four ASX shares falling on Wednesday. Here's why.

Market wrap: ASX falls after CPI inflation shock | news.com.au — Australia's leading news site

Neuren Reveals Major Advances in Pitt Hopkins Syndrome Trial

Neuren's NNZ-2591 Shows Promise for Pitt Hopkins

Neuren Pharmaceuticals Limited (AU:NEU) has released an update. Neuren Pharmaceuticals Limited has announced promising Phase 2 clinical trial resul.